Estatina: Diferenzas entre revisións

de Waal BA, Buise MP, van Zundert AA|title=Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review|volume=114|issue=1|pages=44–52|date=January 2015|journal=Br J Anaesth|pmid=25186819|doi= 10.1093/bja/aeu295}}</ref> A mortalida<demortalidade e os episodios adversos cardiovasculares reducíronse nos grupos que recibiron estatinas.<ref>{{Cite journal|author=Antoniou GA, Hajibandeh S, Hajibandeh S, Vallabhaneni SR, Brennan JA, Torella F|title=Meta-analysis of the effects of statins on perioperative outcomes in vascular and endovascular surgery|volume=S0741-5214|issue=14|pages=01903-X|date=December 2014|journal=J Vasc Surg|pmid=25498191|doi=10.1016/j.jvs.2014.10.021}}</ref>